XML 57 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Income Statement [Abstract]    
Molecular diagnostic testing $ 171.9 $ 164.5
Pharmaceutical and clinical services 11.6 4.3
Total revenue 183.5 168.8
Costs and expenses:    
Cost of molecular diagnostic testing 30.9 32.8
Cost of pharmaceutical and clinical services 5.6 2.1
Research and development expense 17.2 22.6
Selling, general, and administrative expense 86.5 85.4
Total costs and expenses 140.2 142.9
Operating income 43.3 25.9
Other income (expense):    
Interest income 0.1 0.1
Other 0.1 (0.1)
Total other income: 0.2  
Income before income tax 43.5 25.9
Income tax provision 16.9 9.9
Net income $ 26.6 $ 16.0
Earnings per share:    
Basic $ 0.39 $ 0.22
Diluted $ 0.37 $ 0.21
Weighted average shares outstanding:    
Basic 68.7 72.8
Diluted 72.1 76.1